News

PHI expands into Australia and respiratory research

In April Phase Holographic Imaging (PHI) had outstanding orders of approx­imately 2 MSEK, consisting of 13 HoloMonitor M4 units and 15 orders for the recently launched motorized stage. A portion of these units have now been delivered. Among others, a HoloMonitor M4 with motorized stage has been delivered to one of the leading institutes for

Read More

Germany’s largest biomedical research institute foster the use of PHI technology

German Cancer Research Center (DKFZ) in Heidelberg and PHI have signed a collaboration agreement, to foster the use of HoloMonitor technology at DKFZ. A HoloMonitor M4 with a motorized XY-stage will be centrally installed at the Imaging and Cytometry Core Facility and made available to the over 1 000 cancer researchers at DKFZ. “DKFZ is one

Read More

PHI expands collaboration with Karolinska Institutet

Arne Lindqvist and his research group Karolinska Institutet and PHI have entered a second research agreement. Assistant Professor Lindqvist’s research group studies how DNA-damage affects human cell division. To facilitate this research, the group actively develops novel microscopy-based techniques.   PHI will support Professor Lindqvist’s research by providing HoloMonitor instrument, training and support during six

Read More

Research based on HoloMonitor technology to be present at the annual meeting of the American Association for Cancer Research

Northeastern University scientists, associated with the Holographic Imaging Cytometry Program of Excellence, have been selected to present their research results at three occasions at the annual meeting of the American Association for Cancer Research (AACR) in April 2015. In their research, the scientists have used the HoloMonitor M4 time-lapse cytometer from Phase Holographic Imaging to

Read More